Paper12190867
Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus.
Arikawa J and 5 others. J Invest Dermatol, 2002. Cited by 195 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. Papers, record 12190867. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12190867
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dermatitis, Atopic | Major topic |
| Epidermis | Major topic |
| Sphingosine | Major topic |
| Staphylococcus aureus | Major topic |
| Adolescent | |
| Adult | |
| Ceramides | |
| Galactosylgalactosylglucosylceramidase | |
| Humans |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01591785 | Treatment of Staphylococcus Aureus Colonization in Hand Eczema | Background |
Source ClinicalTrials.gov
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 195 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,550,589 | Sphingosine synergizes with polymyxin antibiotics against Pseudomonas aeruginosa and Klebsiella pneumoniae. | Microbiology (Reading) | 2026 | https://conductscience.org/library/papers/42550589 | PubMed |
| 42,169,777 | Proteomic and metabolomic profiling of methicillin-resistant Staphylococcus aureus associated with invasive vs. non-invasive infections: uncovering key biomarkers and pathogenic pathways. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42169777 | PubMed |
| 42,076,775 | Some of the Newest Therapeutic Methods in Canine Atopic Dermatitis. | Vet Sci | 2026 | https://conductscience.org/library/papers/42076775 | PubMed |
| 41,873,507 | Acid ceramidase overactivity drives ceramide loss, leading to atopic dry skin and Th2-skewed immune polarization. | J Pathol | 2026 | https://conductscience.org/library/papers/41873507 | PubMed |
| 41,570,988 | Acid ceramidase ASAH1 is a key regulator of epidermal ceramide levels and composition. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41570988 | PubMed |
| 41,462,194 | Feasibility of salivary lipid screening for caries biomarkers in young adults. | BMC Oral Health | 2025 | https://conductscience.org/library/papers/41462194 | PubMed |
| 39,791,474 | The Pseudomonas aeruginosa sphBC genes are important for growth in the presence of sphingosine by promoting sphingosine metabolism. | Microbiology (Reading) | 2025 | https://conductscience.org/library/papers/39791474 | PubMed |
| 39,300,135 | Gut symbiont-derived sphingosine modulates vector competence in Aedes mosquitoes. | Nat Commun | 2024 | https://conductscience.org/library/papers/39300135 | PubMed |
| 39,282,278 | The Pseudomonas aeruginosa sphBC genes are important for growth in the presence of sphingosine by promoting sphingosine metabolism. | bioRxiv | 2024 | https://conductscience.org/library/papers/39282278 | PubMed |
| 39,235,696 | Isolation of the novel phage SAP71 and its potential use against Staphylococcus aureus in an atopic dermatitis mouse model. | Virus Genes | 2024 | https://conductscience.org/library/papers/39235696 | PubMed |
| 38,375,021 | Microbiome: Role in Inflammatory Skin Diseases. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/38375021 | PubMed |
| 37,623,895 | Bacterial Metabolites and Inflammatory Skin Diseases. | Metabolites | 2023 | https://conductscience.org/library/papers/37623895 | PubMed |
| 37,511,095 | The Interplay between Bioactive Sphingolipids in the Psoriatic Skin and the Severity of the Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37511095 | PubMed |
| 37,167,061 | Competition between skin antimicrobial peptides and commensal bacteria in type 2 inflammation enables survival of S. aureus. | Cell Rep | 2023 | https://conductscience.org/library/papers/37167061 | PubMed |
| 36,835,363 | The Skin Microbiome: Current Landscape and Future Opportunities. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36835363 | PubMed |
| 36,830,346 | A Multiomic Analysis of Chicken Serum Revealed the Modulation of Host Factors Due to Campylobacter jejuni Colonization and In-Water Supplementation of Eugenol Nanoemulsion. | Animals (Basel) | 2023 | https://conductscience.org/library/papers/36830346 | PubMed |
| 36,362,149 | A Nano-Emulsion Containing Ceramide-like Lipo-Amino Acid Cholesteryl Derivatives Improves Skin Symptoms in Patients with Atopic Dermatitis by Ameliorating the Water-Holding Function. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36362149 | PubMed |
| 36,157,249 | Living symbiotic bacteria-involved skin dressing to combat indigenous pathogens for microbiome-based biotherapy toward atopic dermatitis. | Bioact Mater | 2023 | https://conductscience.org/library/papers/36157249 | PubMed |
| 35,532,353 | Mechanisms and Implications of Bacterial Invasion across the Human Skin Barrier. | Microbiol Spectr | 2022 | https://conductscience.org/library/papers/35532353 | PubMed |
| 35,433,501 | Antimicrobial Tear Lipids in the Ocular Surface Defense. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35433501 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ASAH1 | 427 | PubTator's text mining | https://conductscience.org/library/genes/427 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12190867
GET https://conductscience.org/api/papers/v1/12190867/cited_by?page=2